MedTrace Logo

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

NCT06209853 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-07-15

No results posted yet for this study

Summary

It is a cross sectional study aimed to correlate between PSA Levels and F-18 PSMA PET/CT Scan findings and to evaluate the impact of PET/CT findings on the patient management

Conditions

  • Prostatic Neoplasms

Interventions

DEVICE

PSMA PET/CT

Patients need no specific preparation. F-18 PSMA dose will be 3-4 MBq/kg and injected via IV route scan will be performed 90-120 min after injection

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nadia M Moustafa, PhD degree · Assiut University

  • Aalaa W Hussein, master · Assiut University

  • Mohamed A Mekkawy, PhD degree · Assiut University

  • Nahla M mahmoud, PhD degree · Assiut University

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-20
Primary Completion
2025-03-01
Completion
2025-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06209853 on ClinicalTrials.gov